The inaugural Inflammasome Therapeutics Summit (ITS) is the industry’s first dedicated discussion and networking forum focused on bringing together inflammasome thought-leaders to share their latest scientific progress and address the current challenges drug developers are facing.
Join 60+ of your peers and be part of this unique opportunity to engage in cross-industry discussions and presentations from over 19 expert speakers.
With a mission to bridge the gap between research and drug development and develop clinically effective candidates for inflammatory driven diseases, ITS will hone in on the latest developments, insights and science to elevate clinically effective inflammasome therapeutic pipelines.
Developed in combination with experts from Nodthera, Pfizer and IFM Therapeutics and other leading organisations.
To learn more about this event, and to register online, visit https://ter.li/su3nfj